Literature DB >> 9207750

Effect of steroid therapy on parameters of peripheral autonomic dysfunction in leprosy patients with acute neuritis.

A Wilder-Smith1, E Wilder-Smith.   

Abstract

Recent electrophysiological studies on peripheral autonomic dysfunction in leprosy patients show a high prevalence of autonomic dysfunction as measured by abnormal vasomotor reflexes (VMR) and absent sympathetic skin response (SSR). Nothing is known about the reversibility of these autonomic parameters with treatment. Since there is evidence that small fiber function may be the most reversible component in neuropathies, we measured the effect of steroid treatment on autonomic parameters together with motor and sensory functions in leprosy patients with acute neuritis. Control subjects were investigated for repeatability testing of autonomic function. Due to a relatively high variability on repeat VMR testing in the controls, we defined a change in VMR testing as a change of > 30%. With this definition, the VMR of 14.8% of the patients improved, 75% remained unchanged, and 10.2% worsened. Absent SSR became positive in 16.6% and remained unchanged in 83.4%. Improvement in sensory motor functions was seen in 21.2% and 1.3% of the patients, respectively.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9207750

Source DB:  PubMed          Journal:  Int J Lepr Other Mycobact Dis        ISSN: 0148-916X


  3 in total

1.  Progression of leprosy neuropathy: a case series study.

Authors:  Robson T Vital; Ximena Illarramendi; Osvaldo Nascimento; Mariana A Hacker; Euzenir N Sarno; Marcia R Jardim
Journal:  Brain Behav       Date:  2012-05       Impact factor: 2.708

2.  Peripheral Neuropathy Due to Leprosy.

Authors:  Sharon P. Nations; Richard J. Barohn
Journal:  Curr Treat Options Neurol       Date:  2002-05       Impact factor: 3.972

3.  Heart rate variability in multibacillar leprosy: Linear and nonlinear analysis.

Authors:  Marcio Clementino de Souza Santos; Luiz Carlos de Lima Silveira; Sílvia Cristina Garcia Moura-Tonello; Alberto Porta; Aparecida Maria Catai; Givago da Silva Souza
Journal:  PLoS One       Date:  2017-07-27       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.